Dexlansoprazole delayed release
NDC 53401-030, dexlansoprazole, capsule, delayed release, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 53401-030
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202666
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53401-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXLANSOPRAZOLE30 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53401-030-88 | 53401003088 | 900 CAPSULE, DELAYED RELEASE in 1 BOTTLE (53401-030-88) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/59e0c5d7-12e9-b5d7-e063-6394a90a7366
Use it
Look up 53401-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53401-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53401-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.